StrokeIschemic Attack, TransientBrain IschemiaCerebral HemorrhageIntracranial HemorrhagesCerebrovascular DisordersRisk FactorsCerebral InfarctionProspective StudiesFibrinolytic AgentsFollow-Up StudiesTime FactorsCohort StudiesAcute DiseaseTissue Plasminogen ActivatorSubarachnoid HemorrhageTreatment OutcomeRiskThrombolytic TherapyIncidenceAnticoagulantsRecurrenceTomography, X-Ray ComputedIntracranial Hemorrhage, HypertensiveAspirinCarotid StenosisBrain InfarctionIntracranial EmbolismAtrial FibrillationRetrospective StudiesWarfarinPredictive Value of TestsPlatelet Aggregation InhibitorsSeverity of Illness IndexInfarction, Middle Cerebral ArteryCase-Control StudiesComorbidityAge FactorsIntracranial ArteriosclerosisEmbolismRegistriesBrainRisk AssessmentCarotid Artery DiseasesCerebral AngiographyEndarterectomy, CarotidHemorrhageMagnetic Resonance ImagingHypertensionOdds RatioIntracranial Arterial DiseasesRecovery of FunctionIntracranial ThrombosisProportional Hazards ModelsMoyamoya DiseaseNeurologyMultivariate AnalysisNasal DecongestantsCerebrovascular CirculationIntracranial Embolism and ThrombosisMagnetic Resonance AngiographyPrognosisCerebral ArteriesSex FactorsJapanSecondary PreventionParesisDiffusion Magnetic Resonance ImagingFactor XIIIaMyocardial InfarctionRandomized Controlled Trials as TopicUnited StatesCarotid Artery, InternalVertebrobasilar InsufficiencyHemangioma, Cavernous, Central Nervous SystemPhenylpropanolamineLogistic ModelsCarotid ArteriesCerebral RevascularizationEmergency Medical ServicesEndarterectomyHospitalizationSex DistributionCardiovascular DiseasesUltrasonography, Doppler, TranscranialBrain EdemaBasal Ganglia HemorrhageAge DistributionBlood PressureStroke, LacunarNeurologic ExaminationBiological MarkersRegression AnalysisInfarction, Posterior Cerebral ArteryDouble-Blind MethodNeuroprotective AgentsSwedenDatabases, FactualAmaurosis FugaxSmoking